Pharmafile Logo
Pharmafocus logo
Advanced Search

Epogen

Showing 5 posts of 5 posts found.

Pfizer scores approval for first Epogen/Procrit biosimilar in the US

May 16, 2018
Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …

News

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017
Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

News
Amgen image

Amgen unveils plan to close Epogen plant

August 14, 2012
Manufacturing and Production Amgen, Epogen, cuts, omontys

Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …

News

Approval for Affymax and Takeda’s anaemia treatment

March 29, 2012
Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys

The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …

News
Biotech company Amgen's headquarters

Glass flakes lead Amgen to order Epogen and Procrit recall

September 27, 2010
Manufacturing and Production Amgen, Centocor Ortho Biotech, Epogen, Procrit, manufacturing compliance, recalls

Amgen has taken what it describes as a precautionary measure and recalled lots of two of its erythropoietin-based products Epogen …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025